During the past decade, Arensia Exploratory Medicine conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arensia Exploratory Medicine" #1 sponsor was "Janssen Research & Development, LLC" with 8 trials, followed by "Alios Biopharma Inc." with 2 trials sponsored, "Astellas Pharma Europe B.V." with 2 trials sponsored, "Medivir" with 2 trials sponsored and "Arbutus Biopharma Corporation" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arensia Exploratory Medicine" #1 collaborator was "Medivation, Inc." with 2 trials as a collaborator, "Janssen Pharmaceutica" with 1 trials as a collaborator and "Vertex Pharmaceuticals Incorporated" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Arensia Exploratory Medicine" are "Leukemia, Lymphocytic, Chronic, B-Cell" (2 trials), "Lymphoma, Non-Hodgkin" (2 trials), "Osteoarthritis, Knee" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Blood Cancer" (1 trials). Many other conditions were trialed in "Arensia Exploratory Medicine" in a lesser frequency.

Most popular intervention types in "Arensia Exploratory Medicine" are "Drug" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "JNJ-64264681" (2 trials), "MIV-711" (2 trials), "Niraparib" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arensia Exploratory Medicine" are 14 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Arensia Exploratory Medicine". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Arensia Exploratory Medicine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Arensia Exploratory Medicine, 12 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".